Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 199
Gene Symbol: AIF1
AIF1
0.020 AlteredExpression disease BEFREE Increased expression of AIF-1 was observed in several diseases, including endometriosis, breast cancer, atherosclerosis, rheumatoid arthritis, and fibrosis. 31830499 2020
Entrez Id: 54361
Gene Symbol: WNT4
WNT4
0.200 GeneticVariation disease BEFREE This might constitute the first step towards identifying polymorphism combinations that predispose to endometriosis (IFNG (CA) repeat, GSTM1 null genotype, GSTP1 rs1695, WNT4 rs16826658 and WNT4 rs2235529) in a large cohort of patients with well-defined inclusion criteria. 31821471 2020
Entrez Id: 2944
Gene Symbol: GSTM1
GSTM1
0.100 GeneticVariation disease BEFREE This might constitute the first step towards identifying polymorphism combinations that predispose to endometriosis (IFNG (CA) repeat, GSTM1 null genotype, GSTP1 rs1695, WNT4 rs16826658 and WNT4 rs2235529) in a large cohort of patients with well-defined inclusion criteria. 31821471 2020
Entrez Id: 2952
Gene Symbol: GSTT1
GSTT1
0.100 GeneticVariation disease BEFREE The remaining five of the 28 polymorphisms were not associated with endometriosis: glutathione S-transferase theta 1 (GSTT1) null genotype, vascular endothelial growth factor alpha (VEGFA) rs699947, rs833061, rs2010963 and rs3025039. 31821471 2020
Entrez Id: 3458
Gene Symbol: IFNG
IFNG
0.080 GeneticVariation disease BEFREE This might constitute the first step towards identifying polymorphism combinations that predispose to endometriosis (IFNG (CA) repeat, GSTM1 null genotype, GSTP1 rs1695, WNT4 rs16826658 and WNT4 rs2235529) in a large cohort of patients with well-defined inclusion criteria. 31821471 2020
Entrez Id: 2950
Gene Symbol: GSTP1
GSTP1
0.060 GeneticVariation disease BEFREE This might constitute the first step towards identifying polymorphism combinations that predispose to endometriosis (IFNG (CA) repeat, GSTM1 null genotype, GSTP1 rs1695, WNT4 rs16826658 and WNT4 rs2235529) in a large cohort of patients with well-defined inclusion criteria. 31821471 2020
Entrez Id: 94025
Gene Symbol: MUC16
MUC16
0.100 AlteredExpression disease BEFREE Through comparison, significant differences were identified between the pain and painless groups with regard to age at diagnosis (P=0.009), age at onset of disease (P=0.008), and level of pre-surgical CA125 (P<0.001), as well as proportion of patients with rectal irritation (P=0.008), elevated CA125 level (P<0.001), thickened myometrial layer (P<0.001) and concurrent endometriosis (P=0.001). 31814754 2019
Entrez Id: 5241
Gene Symbol: PGR
PGR
0.600 Biomarker disease BEFREE Dienogest, a specific progesterone receptor agonist, is used in the treatment of endometriosis. 31814016 2020
Entrez Id: 378938
Gene Symbol: MALAT1
MALAT1
0.070 GeneticVariation disease BEFREE The MALAT1 rs591291 C > T polymorphism was associated with a significant increase in endometriosis risk. 31803924 2019
Entrez Id: 94081
Gene Symbol: SFXN1
SFXN1
0.010 GeneticVariation disease BEFREE Compared with wild-type CCG haplotype carriers, individuals with TCC haplotypes had a higher risk of developing endometriosis. 31803924 2019
Entrez Id: 7040
Gene Symbol: TGFB1
TGFB1
0.100 Biomarker disease BEFREE Transforming growth factor-β1 (TGF-β1) is elevated in the peritoneal fluid from women with endometriosis, and exposure of HPMCs to TGF-β1 exacerbates this abnormal phenotype. 31792175 2019
Entrez Id: 9048
Gene Symbol: ARTN
ARTN
0.090 Biomarker disease BEFREE <b>Conclusion:</b> Freeze-all strategy is an attractive option to improve the outcomes of ART for women with advanced endometriosis. 31787933 2019
Entrez Id: 181
Gene Symbol: AGRP
AGRP
0.090 Biomarker disease BEFREE <b>Conclusion:</b> Freeze-all strategy is an attractive option to improve the outcomes of ART for women with advanced endometriosis. 31787933 2019
Entrez Id: 115908
Gene Symbol: CTHRC1
CTHRC1
0.010 Biomarker disease BEFREE In addition, the serum concentration of CTHRC1 was apparently higher in the endometriosis group than the control group. 31787549 2019
Entrez Id: 5972
Gene Symbol: REN
REN
0.030 Biomarker disease BEFREE Tanshinone IIA contributes to the pathogenesis of endometriosis via renin angiotensin system by regulating the dorsal root ganglion axon sprouting. 31759042 2020
Entrez Id: 183
Gene Symbol: AGT
AGT
0.020 Biomarker disease BEFREE The Tanshinone IIA inhibitory effect on the EMs associated pain in EMs rats might occur through decreasing the expression of E2, ANGII and AT2, thus halting DRG sprouting and promoting hyperalgesia threshold. 31759042 2020
Entrez Id: 186
Gene Symbol: AGTR2
AGTR2
0.020 Biomarker disease BEFREE The Tanshinone IIA inhibitory effect on the EMs associated pain in EMs rats might occur through decreasing the expression of E2, ANGII and AT2, thus halting DRG sprouting and promoting hyperalgesia threshold. 31759042 2020
Entrez Id: 79694
Gene Symbol: MANEA
MANEA
0.020 Biomarker disease BEFREE This observational cohort study ENDO-RESECT (ClinicalTrials.gov ID: NCT03824054) reports all clinical data about women who underwent SR for DIE between October 2005 and November 2017. 31758304 2020
Entrez Id: 332
Gene Symbol: BIRC5
BIRC5
0.220 Biomarker disease BEFREE We used the search terms endometriosis and survivin or BIRC5 and collected all relevant studies to explore the association between endometriosis and surviving expression. 31755675 2019
Entrez Id: 2798
Gene Symbol: GNRHR
GNRHR
0.040 Biomarker disease BEFREE Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis. 31749075 2020
Entrez Id: 406952
Gene Symbol: MIR17
MIR17
0.040 Biomarker disease BEFREE On studying the relation between the positivity of endometrial tissue culture and miR-17-5p and so endometriosis, <i>P</i> value was <0.0001*. 31747809 2019
Entrez Id: 574411
Gene Symbol: MIR451A
MIR451A
0.080 AlteredExpression disease BEFREE Hsa-miR-451 in FF was downregulated in endometriosis patients relative to control subjects (P < 0.01). 31744497 2019
Entrez Id: 2243
Gene Symbol: FGA
FGA
0.020 AlteredExpression disease BEFREE FGA concentrations in serum and expression in eutopic and ectopic endometrial tissue were significantly higher in women with endometriosis than controls (P < 0.05 and P < 0.01 respectively), whereas FGA expression was not significantly different in eutopic compared with ectopic endometrial tissues from the same patients. 31740226 2019
Entrez Id: 5444
Gene Symbol: PON1
PON1
0.020 AlteredExpression disease BEFREE Among 10 studies that included 407 patients with surgically proven endometriosis and 557 controls, RR of developing hypercholesterolemia and hypertension were 1.25 and 1.14, respectively, while higher serum lipoprotein a and lower paraoxonase 1 levels were found in women with endometriosis that was negatively correlated with stage of disease (r = -0.74, P < 0.0001). 31735549 2019
Entrez Id: 4018
Gene Symbol: LPA
LPA
0.020 AlteredExpression disease BEFREE Among 10 studies that included 407 patients with surgically proven endometriosis and 557 controls, RR of developing hypercholesterolemia and hypertension were 1.25 and 1.14, respectively, while higher serum lipoprotein a and lower paraoxonase 1 levels were found in women with endometriosis that was negatively correlated with stage of disease (r = -0.74, P < 0.0001). 31735549 2019